CRO Sector Rises 2.06% as Boji Pharma Leads Gains on Aug 13, 2026
On August 13, 2026, the CRO sector rallied sharply, with the overall index climbing 2.06%. Boji Pharma led the advance, rising over 10% before extending gains to more than 12%. Saifen Technology, Haoyuan Pharma, and Pharmaron also posted strong gains. Meanwhile, the innovative drug sector rebounded from session lows, with Ruilian New Materials, Yuhuan Pharma, ACROBiosystems, and Apeloa among the gainers.
On August 13, 2026, the biotech sector saw a rally, with Boji Pharma rising over 10%. Saifen Technology, Haoyuan Pharma, and Pharmaron followed suit. At the same time, the innovative drug sector showed a rebound from lows, with Boji Pharma extending gains to over 12%. Ruilian New Materials, Yuhuan Pharma, Pharmaron, ACROBiosystems, and Apeloa also rose in tandem.
The CRO sector rallied rapidly that day, with the overall sector gain expanding to 2.06%. Boji Pharma, Pharmaron, and Haoyuan Pharma were among the top gainers.